Immune checkpoint expression in head and neck cancer

被引:0
|
作者
Puntigam, L. [1 ]
Jeske, S. [1 ]
Brunner, C. [2 ]
Hoffmann, T. [3 ]
Schuler, P. [2 ]
机构
[1] Univ Klin Ulm, Kopf Hals Tumorzentrum Ulm, Klin Hals Nasen Ohrenheilkunde & Kopf Hals Chirur, Ulm, Germany
[2] Univ Klin Ulm, Klin Hals Nasen Ohrenheilkunde & Kopf Hals Chirur, Ulm, Germany
[3] Univ Klin Ulm, Klin Hals Nasen Ohrenheilkunde Kopf & Halschirurg, Klin Hals Nasen Ohrenheilkunde, Ulm, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
609
引用
收藏
页码:96 / 97
页数:2
相关论文
共 50 条
  • [1] Immune checkpoint expression on lymphocyte populations in head and neck cancer patients
    Puntigam, L. K.
    Jeske, S. S.
    Brunner, C.
    Hoffmann, T. K.
    Schuler, P. J.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 296 - 296
  • [2] Immune Checkpoint Inhibition in Head and Neck Cancer
    Forster, Martin David
    Devlin, Michael-John
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [3] Immune Checkpoint Protein for Monitoring Head and Neck Cancer Prognosis
    Lakshmipriya, Thangavel
    Gopinath, Subash C. B.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2024,
  • [4] Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade
    Wang, Wei
    Lozar, Taja
    Golfinos, Athena E.
    Lee, Denis
    Gronski, Ellery
    Ward-Shaw, Ella
    Hayes, Mitchell
    Bruce, Justine Y.
    Kimple, Randall J.
    Hu, Rong
    Harari, Paul M.
    Xu, Jin
    Keske, Aysenur
    Sondel, Paul M.
    Fitzpatrick, Megan B.
    Dinh, Huy Q.
    Lambert, Paul F.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2953 - 2968
  • [5] Immune Checkpoint Therapy in Head and Neck Cancers
    Msaouel, Pavlos
    Massarelli, Erminia
    [J]. CANCER JOURNAL, 2016, 22 (02): : 108 - 116
  • [6] Checkpoint inhibitors in head and neck cancer
    Ilson Sepulveda
    Rodrigo Ascui
    A. Andrés Capizzano
    [J]. memo - Magazine of European Medical Oncology, 2019, 12 : 249 - 252
  • [7] Checkpoint inhibitors in head and neck cancer
    Sepulveda, Ilson
    Ascui, Rodrigo
    Capizzano, A. Andres
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (03) : 249 - 252
  • [8] Checkpoint Inhibition in Head and Neck Cancer: Immune Therapeutic Options, Limitations, and Beyond
    Hoechst, Bastian
    Knolle, Percy A.
    [J]. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2017, 79 (1-2): : 24 - 33
  • [9] Efficacy of Chemotherapy After Immune Checkpoint Inhibitor Discontinuation in Head and Neck Cancer
    Fukuoka, Osamu
    Saito, Yuki
    Mukai, Toshiyuki
    Hayashi, Takaaki
    Yamamura, Koji
    Sakai, Toshihiko
    Kobayashi, Kenya
    Akashi, Ken
    Yoshida, Masafumi
    Ando, Mizuo
    Yamasoba, Tatsuya
    [J]. LARYNGOSCOPE, 2024, 134 (01): : 228 - 235
  • [10] Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management
    Wang, Haiyang
    Mustafa, Abdulkadir
    Liu, Shixi
    Liu, Jun
    Lv, Dan
    Yang, Hui
    Zou, Jian
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10